Frank Zavrl

Director/Board Member at CERVOMED INC.

Net worth: 1 M $ as of 31/05/2026

60 year

28 connections

Finance

Consumer Services

Health Technology

Profile

Frank E.
Zavrl currently works at CervoMed, Inc., as Independent Director from 2023.
Mr. Zavrl also formerly worked at Puma Biotechnology, Inc., as Independent Director from 2015 to 2020, EIP Pharma, Inc., as Non-Executive Director from 2018 to 2023, EIP Pharma LLC, as Director from 2017 to 2018, Adage Capital Management LP, as Equity Analyst, Zurich Scudder Investments, Inc., as Analyst from 1998 to 1999, and Merlin Biomed Group LLC, as Portfolio Manager from 1999 to 2002.
Mr. Zavrl received his undergraduate degree from the University of California, Berkeley and Masters Business Admin degree from Tuck School of Business at Dartmouth.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CERVOMED INC. 3.81%	08/06/2026	353,009 ( 3.81% )	1 M $	31/05/2026

Frank Zavrl active positions

Companies	Position	Start
CERVOMED INC.	Director/Board Member	16/08/2023

All active positions of Frank Zavrl

Former positions of Frank Zavrl

Companies	Position	End
EIP Pharma, Inc. EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases	Director/Board Member	01/08/2023
PUMA BIOTECHNOLOGY, INC.	Director/Board Member	06/07/2020
EIP Pharma LLC	Director/Board Member	01/03/2018
Merlin Biomed Group LLC Merlin Biomed Group LLC Investment ManagersFinance Alternative investment manager	Corporate Officer/Principal	01/01/2002
Zurich Scudder Investments, Inc. Zurich Scudder Investments, Inc. Regional BanksFinance Provides investment management services	Corporate Officer/Principal	01/01/1999

See the detail of Frank Zavrl's experience

Training of Frank Zavrl

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Frank Zavrl's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Adage Capital Management LP Adage Capital Management LP Investment ManagersFinance Adage manages ACP primarily through industry-specific portfolios that are managed by analyst/portfolio manager teams or individuals. The ACP aims to provide investors with compound annual long-term returns that outperform the returns of the S&P 500 Index. Their analysts focus on adding value by stock selection based on intra-industry fundamental analysis. In addition to taking long positions, the firm uses leverage, sells securities short, and invests in derivatives, US and non-US equities and private securities.	Finance
Zurich Scudder Investments, Inc. Zurich Scudder Investments, Inc. Regional BanksFinance Provides investment management services	Finance
University of California, Berkeley University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Merlin Biomed Group LLC Merlin Biomed Group LLC Investment ManagersFinance Alternative investment manager	Finance
Tuck School of Business at Dartmouth Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Puma Biotechnology, Inc. Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer	Health Technology
EIP Pharma, Inc. EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases	Health Technology
EIP Pharma LLC
CervoMed, Inc. CervoMed, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops novel therapies	Commercial Services